worldwid
outbreak
sever
acut
respiratori
syndrom
sar
caus
high
rate
mortal
main
proteas
pro
sarsassoci
coronaviru
sarscov
import
target
discov
pharmaceut
compound
therapi
lifethreaten
diseas
cours
screen
new
antisar
agent
identifi
seri
unsymmetr
aromat
disulfid
inhibit
sarscov
pro
significantli
first
time
herein
novel
unsymmetr
aromat
disulfid
synthes
chemic
biolog
activ
evalu
vitro
sarscov
pro
novel
compound
display
excel
ic
data
rang
mm
preliminari
studi
indic
disulfid
revers
mpetit
inhibitor
possibl
bind
mode
gener
via
molecular
dock
simul
compar
field
analysi
comfa
model
construct
understand
structureact
relationship
present
research
therefor
provid
meaning
guidanc
design
identifi
antisar
drug
total
new
chemic
structur
sever
acut
respiratori
syndrom
sar
highli
infect
respiratori
diseas
caus
sar
coronaviru
sarscov
sudden
emerg
rapid
outbreak
result
death
among
report
individu
case
worldwid
although
sar
epidem
control
year
reemerg
threaten
ill
still
possibl
risk
potenti
new
strain
sar
danger
previou
one
number
import
target
recogn
take
part
biolog
event
critic
sarscov
replic
among
papainlik
proteas
pl
pro
chymotrypsinlik
proteas
pro
signific
import
design
antisar
inhibitor
pro
also
known
main
proteas
pro
attract
much
attent
could
reveal
numer
public
novel
inhibitor
discoveri
crystal
structur
sarscov
pro
either
free
enzym
alon
complex
inhibitor
determin
facilit
structur
function
investig
proteas
activ
site
sarscov
pro
contain
constitut
catalyt
dyad
cystein
function
common
nucleophil
proteolyt
process
biolog
activ
inhibitor
sarscov
pro
report
mainli
two
differ
approach
one
screen
larg
librari
identifi
new
activ
compound
use
highthroughput
techniqu
novel
inhibitor
design
base
substrat
structur
activ
site
properti
ration
inhibitori
activ
compound
valid
vitro
proteas
assay
case
kinet
studi
indic
inhibitor
involv
irrevers
process
form
coval
bond
case
inhibit
actual
revers
behavior
report
sarscov
pro
inhibitor
cover
varieti
differ
chemic
scaffold
contain
peptidomimet
compound
carboxyl
acid
deriv
deriv
zincconjug
compound
cinanserin
calmodulin
ketoglutamin
analogu
anilid
bifunct
boron
acid
compound
isatin
deriv
etacryn
acid
deriv
serin
deriv
trifluoromethyl
keton
acetamid
pyrazolon
quercertin
piti
research
drug
vaccin
toward
sar
sarslik
coronaviru
brought
candid
clinic
use
henc
still
exist
urgent
need
discov
identifi
new
sarscov
pro
agent
especi
compound
total
new
chemic
famili
develop
effect
therapi
fatal
viral
infect
disulfid
bond
play
essenti
role
bioactiv
protein
keep
correct
fold
case
simpl
disulfid
diallyl
disulfid
dimethyl
disulfid
exhibit
hypochlor
acid
scaveng
activ
tyrosinas
inhibitori
activ
fig
unsymmetr
disulfid
compound
use
tool
research
dynam
combinatori
chemistri
compound
also
report
display
varieti
biolog
activ
exampl
turo
et
al
report
unsymmetr
arylalkyl
disulfid
inhibitor
methicillinresist
staphylococcu
aureu
bacillu
anthraci
fig
khosla
cowork
publish
unsymmetr
disulfid
could
select
inhibit
extracellular
thioredoxin
fig
yoon
et
al
show
unsymmetr
disulfid
compound
inhibitor
mycobacterium
tuberculosi
haemophilu
influenza
interf
acetohydroxyacid
synthas
aha
key
enzym
biosynthesi
pathway
branch
chain
aminoacid
fig
past
research
found
unsymmetr
aromat
disulfid
could
inhibit
plant
aha
use
herbicid
research
fig
inde
report
aromat
disulfid
exhibit
antivir
activ
virucid
activ
due
target
arenaviru
rna
synthesi
fig
acid
dtnb
antivir
propierti
ttropic
human
immunodefici
viru
type
fig
antivir
disulfid
compound
could
block
interact
arenaviru
z
protein
cellular
promyelocyt
leukemia
protein
fig
howev
antivir
activ
arenaviru
might
differ
coronaviru
evid
report
antivir
activ
aromat
disulfid
direct
relationship
sarscov
pro
inhibit
effort
discov
novel
inhibitor
sarscov
pro
synthes
seri
novel
unsymmetr
aromat
disulfid
evalu
biolog
activ
studi
target
compound
could
inhibit
main
proteas
sarscov
remark
best
ic
valu
mm
subsequ
enzymat
kinet
studi
indic
aromat
disulfid
act
revers
noncompetit
inhibitor
therefor
demonstr
unsymmetr
disulfid
compound
aromat
ring
novel
inhibitor
sarscov
pro
total
new
chemic
famili
provid
help
inform
drug
discoveri
target
unsymmetr
disulfid
synthes
reaction
variou
substitut
oxadiazol
substitut
substitut
substitut
substitut
arenesulfenyl
chlorid
ethyl
ether
mild
condit
report
previous
quit
straightforward
nucleophil
substitut
thiol
group
mercapto
compound
serv
nucleophil
reagent
attack
sulfur
atom
arenesulfenyl
chlorid
yield
reaction
satisfactori
show
simpl
easi
procedur
produc
unsymmetr
aromat
disulfid
superior
synthet
rout
develop
hahn
et
al
hahn
paper
moist
tetrahydrofuran
gave
better
yield
dri
benzen
solvent
reaction
author
ad
equival
water
reaction
mixtur
observ
satisfactori
yield
thu
presenc
water
thought
prefer
reaction
hahn
et
al
synthesi
experi
ethyl
ether
use
solvent
addit
water
ad
reaction
nevertheless
observ
high
yield
target
compound
essbond
confirm
previou
paper
compound
acetyl
correspond
parent
compound
publish
us
molecular
structur
compound
list
tabl
titl
compound
fulli
character
h
nmr
c
nmr
hrm
part
supplementari
data
origin
figur
synthes
unsymmetr
aromat
disulfid
subject
vitro
assay
sarscov
pro
result
also
illustr
tabl
express
ic
valu
could
seen
target
compound
exhibit
encourag
biolog
potenc
excel
ic
valu
rang
mm
mm
inhibit
curv
target
compound
found
part
supplementari
data
surpris
due
fact
research
group
ever
identifi
disulfid
compound
inhibitor
sarscov
pro
mention
strong
inhibit
inhibit
type
disulfid
determin
mean
enzymat
kinet
studi
use
fig
seen
plot
enzym
concentr
versu
reaction
veloc
line
repres
differ
inhibitor
concentr
intersect
point
suggest
inhibit
actual
revers
action
measur
enzymat
veloc
sarscov
pro
versu
substrat
concentr
presenc
either
part
supplementari
data
line
display
reciproc
plot
intersect
point
indic
inhibitor
serv
noncompetit
inhibitor
part
supplementari
data
basi
kinet
paramet
ak
mm
k
mm
determin
fig
clearli
prove
noncompetit
inhibitor
character
smaller
equilibriumbind
constant
compar
known
inhibitor
k
mm
k
mm
sinc
cystein
activ
site
sarscov
pro
play
essenti
role
biolog
activ
proteas
possibl
disulfid
compound
react
form
new
essbond
result
loss
enzym
activ
known
disulfid
react
anoth
thiol
give
new
disulfid
thiol
part
old
disulfid
also
react
directli
thiol
form
new
disulfid
test
biolog
activ
differ
aryl
thiol
deriv
disulfid
inhibit
sarscov
pro
could
detect
even
high
concentr
accordingli
seem
unlik
form
essbond
react
target
disulfid
compound
anoth
method
rule
possibl
determin
chang
molecular
weight
protein
inhibit
disulfid
compound
react
molecular
weight
would
shift
sarscov
pro
inhibit
approxim
mass
half
moieti
unsymmetr
disulfid
bear
mind
measur
molecular
weight
proteas
inhibit
three
disulfid
compound
signific
structur
differ
data
shown
part
supplementari
data
howev
assum
shift
molecular
weight
observ
support
idea
anoth
possibl
khosla
et
al
report
select
inhibit
extracellular
thioredoxin
unsymmetr
disulfid
two
cystein
residu
close
distanc
form
intramolecular
disulfid
bond
care
analysi
sarscov
pro
crystal
structur
pdb
entri
cystein
residu
found
nearbi
space
fact
two
cystein
residu
reason
distanc
form
possibl
intramolecular
disulfid
bond
thu
also
deni
probabl
inhibitori
mechan
sinc
unsymmetr
aromat
disulfid
react
residu
sarscov
pro
mean
compound
act
intact
molecul
inhibit
proteas
therefor
silico
molecular
dock
techniqu
util
predict
possibl
bind
mode
disulfid
compound
sarscov
pro
previou
studi
dock
small
librari
isatin
compound
activ
site
aha
probabl
bind
mode
predict
flexx
similar
strategi
adopt
carri
databas
dock
investig
result
dock
conform
nineteen
compound
found
overlay
one
anoth
quit
well
part
supplementari
data
twentyon
compound
unreason
bind
space
fail
overlay
well
one
anoth
thu
dock
conform
nineteen
compound
thought
possibl
bind
conform
studi
compound
chosen
depict
bind
mode
disulfid
inhibitor
fig
twodimension
illustr
interact
inhibitor
surround
residu
sarscov
pro
drawn
ligplot
locat
overlap
inhibitor
inhibitor
origin
pdb
file
compound
bind
sarscov
pro
via
multipl
hydrogen
bond
contact
hydrophob
contact
form
hydrophob
interact
small
molecul
form
intermolecular
hbond
inhibitor
predict
bind
mode
therefor
provid
use
clue
understand
possibl
molecular
basi
inhibitor
compar
field
analysi
comfa
tool
gener
contour
model
quantit
analyz
structureact
relationship
bioactiv
compound
steric
electrostat
contribut
basi
dock
conform
molecul
databas
align
construct
comfa
model
compound
exclud
databas
statist
outlier
train
set
inclus
molecul
yield
satisfactori
leaveoneout
q
train
set
without
outlier
gave
leaveoneout
q
optimum
compon
noncrossvalid
r
standard
error
estim
f
valu
steric
electrostat
contribut
respect
compound
use
illustr
steric
electrostat
contour
map
togeth
neighbor
residu
dock
bind
pocket
fig
steric
contour
map
bulki
tabl
novel
unsymmetr
aromat
disulfid
compound
sarscov
pro
inhibitori
activ
ic
group
favor
better
inhibit
green
contour
region
group
like
decreas
activ
yellow
contour
space
green
map
mostli
three
bulk
one
form
one
form
last
one
form
wherea
yellow
map
locat
space
nearbi
electrostat
contour
map
blue
contour
region
increas
posit
charg
lead
increas
activ
yet
red
contour
region
neg
charg
favor
enhanc
activ
blue
map
region
surround
wherea
red
map
three
caviti
one
form
one
form
last
one
form
comfa
map
afford
import
structur
featur
unsymmetr
aromat
disulfid
steric
electrostat
view
valuabl
design
discoveri
potent
inhibitor
lack
effect
antisar
agent
make
possibl
danger
sar
break
sometim
futur
numer
peopl
kill
therefor
still
urgent
demand
discov
novel
antisar
inhibitor
combat
deadli
diseas
sar
cov
pro
import
target
design
therapeut
use
drug
present
studi
effort
develop
nonpeptid
antisar
inhibitor
identifi
first
time
unsymmetr
aromat
disulfid
excel
inhibitor
sar
cov
pro
mechan
seem
distinct
revers
mpetit
inhibitor
suggest
unsymmetr
disulfid
promis
lead
compound
identif
develop
new
famili
biolog
activ
antisar
agent
possibl
bind
model
disulfid
inhibitor
built
molecular
dock
comfa
model
construct
subsequ
point
structur
featur
novel
inhibitor
sar
cov
pro
base
inform
structur
modif
ongo
better
pharmaceut
compound
lipinski
rule
also
util
help
develop
compound
final
vivo
activ
also
tri
cocrystal
proteas
best
inhibitor
gain
insight
real
bind
mode
explain
molecular
basi
compound
variou
heterocycl
aromat
thiol
commerci
procur
pharmatech
china
apichem
china
aldrich
ace
pharma
puriti
grade
solvent
liquid
reagent
dri
advanc
use
standard
method
distil
use
substitut
arenesulfenyl
chlorid
synthes
describ
previou
public
synthet
method
compound
report
parent
compound
also
fulli
character
melt
point
determin
use
melt
apparatu
uncorrect
h
nmr
spectra
c
nmr
obtain
use
mhz
varian
mercuri
plu
spectromet
chemic
shift
valu
nmr
spectra
report
part
per
million
ppm
use
deuter
chloroform
cdcl
dimethyl
sulfoxid
dmsod
solvent
tetramethylsilan
tm
intern
refer
standard
mass
spectra
record
thermo
finnigan
lcq
advantag
lcmass
detector
instrument
heterocycl
aromat
thiol
mmol
ad
solut
freshli
prepar
arenesulfenyl
chlorid
mmol
ml
anhydr
ethyl
ether
room
temperatur
mixtur
stir
h
temperatur
solvent
remov
reduc
pressur
product
purifi
column
chromatographi
yield
unsymmetr
aromat
disulfid
mmol
ad
ml
acet
anhydrid
reaction
mixtur
stir
h
c
ml
water
ad
mixtur
ph
valu
adjust
sodium
bicarbon
product
extract
ethyl
acet
solvent
remov
reduc
pressur
target
compound
final
purifi
express
purif
sar
cov
pro
describ
rao
et
al
basic
sequenc
sarscov
pro
clone
vector
transform
e
coli
cell
gst
fusion
protein
gstsarscov
pro
purifi
gstglutathion
affin
chromatographi
cleav
presciss
proteas
recombin
sarscov
pro
purifi
use
anionexchang
chromatographi
eventu
purifi
protein
high
puriti
judg
sdspage
analysi
concentr
mm
buffer
contain
mm
trishcl
ph
mm
edta
fluorogen
substrat
consensu
sequenc
cov
pro
mcaavlqsgfrli
dnp
puriti
synthes
shanghai
biolog
engin
compani
substrat
dissolv
dmso
mm
liquid
storag
use
inhibit
assay
similar
yang
procedur
sar
cov
pro
inhibit
assay
conduct
fluoresc
reson
energi
transfer
fret
natur
substrat
amino
acid
sequenc
avlqsgfrkk
sarscov
pro
start
mca
fluoresc
group
connect
dnp
fluoresc
quench
group
penultim
k
test
compound
dissolv
steril
dmso
dilut
variou
concentr
settl
concentr
protein
compound
substrat
preheat
c
oscil
excitationemiss
light
nm
test
carri
everi
time
draw
curv
maximum
valu
neg
control
curv
slope
v
largest
compound
curv
slope
inhibit
ratio
defin
v
ic
valu
calcul
equat
use
craphpad
v
show
initi
rate
reaction
without
inhibitor
v
mean
initi
rate
reaction
inhibitor
variou
concentr
indic
concentr
inhibitor
determin
inhibitor
valent
inhibitor
employ
method
well
albeit
two
modif
firstli
inhibitor
concentr
set
mm
inhibitor
concentr
measur
enzymat
activ
pro
whose
concentr
span
mm
secondli
pro
inhibitor
first
incub
min
ensur
thorough
pro
inhibitor
reaction
inhibit
assay
initi
ad
substrat
character
fluoresc
monitor
character
inhibitor
noncompetit
inhibitor
employ
method
describ
earlier
work
basic
enzymat
veloc
sarscov
pro
versu
substrat
concentr
presenc
inhibitor
depict
equat
k
dissoci
constant
sarscov
pro
complex
inhibitor
factor
reflect
effect
inhibitor
affin
enzym
substrat
v
max
k
repres
maximum
veloc
michaelismenten
constant
respect
valu
v
max
k
differ
inhibitor
concentr
appar
v
max
k
call
v
app
max
andk
app
respect
accord
equat
v
app
max
andk
app
calcul
equat
kinet
paramet
v
mass
spectra
record
water
xevo
qtof
mass
spectrometri
mass
spectra
acquir
posit
ion
mode
use
capillari
voltag
kv
sampl
cone
voltag
v
sourc
offset
voltag
v
cone
ga
flow
set
lh
desolv
ga
flow
lh
desolv
temperatur
sourc
temperatur
set
c
c
respect
mass
intact
protein
obtain
deconvolut
raw
data
use
tool
sampl
prepar
similar
condit
ic
determin
except
concentr
inhibitor
time
concentr
sar
pro
chemic
structur
compound
built
within
sybyl
tripo
inc
st
loui
mo
molecul
assign
charg
minim
tripo
forc
field
converg
reach
molecular
dock
unsymmetr
aromat
disulfid
activ
site
sarscov
pro
perform
flexx
crystal
structur
sarscov
pro
complex
inhibitor
pdb
code
retriev
pdb
databank
water
molecul
remov
hydrogen
atom
ad
standard
geometri
amino
acid
residu
within
locat
origin
inhibitor
consid
bind
pocket
cscore
calcul
enabl
set
serial
mode
databas
dock
subsequ
score
procedur
perform
use
default
paramet
program
comfa
molecul
superimpos
use
molecular
dock
result
templat
paramet
use
default
valu
within
comfa
modul
column
filter
set
kcalmol
leaveoneout
loo
cross
valid
method
appli
determin
optimum
number
partial
least
squar
pl
compon
noncross
valid
method
use
deriv
final
model
explain
quantit
structureact
relationship
three
dimension
manner
